about
The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathologyConstitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancersKnockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?Apoptosis: a review of programmed cell deathBrain tumors in Li-Fraumeni syndrome: a commentary and a case of a gliosarcoma patient.Cell cycle control, checkpoint mechanisms, and genotoxic stress.Genes and cancerUmbilical cord blood transplantation.Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators.Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.Haploinsufficient tumor suppressor genes.An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either alleleMolecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review.Evaluation of a decision aid for families considering p53 genetic counseling and testing.Embolic stroke secondary to an aortic arch tumor--a case report.Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses.Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?p53: the barrier to cancer stem cell formation.No excess of early onset cancer in family members of Wilms tumor patients.Hereditary ovarian cancer: not only BRCA 1 and 2 genes.A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.Akt and c-Myc induce stem-cell markers in mature primary p53⁻/⁻ astrocytes and render these cells gliomagenic in the brain of immunocompetent mice.A continuum model for tumour suppression.The MDM2 gene amplification databaseRisk assessment and management of high risk familial breast cancer.The biology of breast carcinoma.Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families.Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.Genetic and molecular alterations across medulloblastoma subgroupsChromosome instability is a predominant trait of fibroblasts from Li-Fraumeni familiesp53 and disease: when the guardian angel fails.Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions.Linking abnormal mitosis to the acquisition of DNA damageTiming and context: important considerations in the return of genetic results to research participants.Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management.Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma
P2860
Q21195242-278F04D1-773B-4C82-AA57-C76DC354E4B3Q24534231-DDB20C8E-CCA4-41E5-AB7D-1E7DDB0B729BQ24802378-F7D27724-9F74-4422-9B19-61EC6975025EQ28305845-EF454807-8A76-49C2-91C6-0DF3AE65C3C3Q31121646-22BBB1A9-A0DF-42FE-95A7-5E392B4B126DQ33608768-7F38FA46-C4A4-4F0B-A03E-BBD0E8C33A56Q33634103-E8D3C9CB-46AE-487F-AC6B-81FA5F1ED48FQ33634109-B55A12ED-CED8-4ED0-A077-D4BC25657E34Q33737277-853602B8-8EE6-47D2-B8D5-800A4EBD1FBCQ33857846-AE8ECB37-8405-449F-A7A8-421C360F12BEQ33864922-72096ED2-C46F-4051-8C71-5DC0A6720A06Q33930947-82D31097-85FC-4C79-948C-1B65188E6925Q34038389-E5E62C48-6322-48C5-BEEE-8195EE63D6BCQ34051118-764DA1B1-974F-4DA3-9C1A-FE5467A040F5Q34093171-9B806D71-522C-4AB3-9343-A406388F097DQ34096930-F174464C-BF3E-45D9-8670-431277C5FB91Q34275810-AAA0670B-646D-46DD-8607-B24A86A4F4A3Q34306492-E56E5D18-3D4D-4B63-A758-52EA2BA5B6FDQ34324683-EBD016DE-1275-44E1-9E3B-82EFF0F09CE2Q34390257-C479EE45-DAF0-4ADB-A59D-69F797B858A8Q34406072-9FF986C0-925E-46CE-BFDE-0A97C2A200B8Q34464257-71D590B6-5701-4C5E-B936-9036DD78EE34Q34480707-86168DC2-893D-49CF-B4B0-53B0F25C1F07Q34521706-1F42D1F4-8421-42B2-A433-B4EB057A64A5Q34592895-9581796B-1A89-46F0-8571-BC538BA60A22Q34631552-8C6E5605-AAA0-4651-9B20-9EA9F386773AQ34672224-F2E7959E-48D6-4A0C-A07F-4F970F27B354Q35019822-1A480881-2F53-4F49-A409-C282411AC604Q35053948-DBB8F225-F315-47E5-93C9-9336560B197BQ35157919-552D622E-29CC-4799-9028-6BE63A11715EQ35355110-E591F5AA-7F26-4E76-AB38-181F25A7640EQ35829654-DBA092D5-005C-4759-BF4B-187A22E1826CQ36142459-10108DC1-50E1-45B3-AABE-7B01D1167A31Q36292945-5BDDB7F7-0CCA-4D14-8F4F-A69FD443E362Q36430165-EDCACB92-1D43-40B3-95D3-583A32F6867BQ36451030-756AAA0C-A698-401B-A28B-594F9DD3528DQ36455900-F3927B40-BD77-44D6-9CE2-F1B79460C752Q36470928-E1EF103B-8F7F-4C65-B7AC-BD8430F49A56Q36493335-5FDD4DD3-6661-46A9-9DDE-AF1079D56D9CQ36508843-7BBF4BF5-52A4-42AF-9685-4D611BEA1B64
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Li-Fraumeni syndrome--a molecular and clinical review.
@ast
Li-Fraumeni syndrome--a molecular and clinical review.
@en
Li-Fraumeni syndrome--a molecular and clinical review.
@nl
type
label
Li-Fraumeni syndrome--a molecular and clinical review.
@ast
Li-Fraumeni syndrome--a molecular and clinical review.
@en
Li-Fraumeni syndrome--a molecular and clinical review.
@nl
prefLabel
Li-Fraumeni syndrome--a molecular and clinical review.
@ast
Li-Fraumeni syndrome--a molecular and clinical review.
@en
Li-Fraumeni syndrome--a molecular and clinical review.
@nl
P2093
P2860
P921
P356
P1476
Li-Fraumeni syndrome--a molecular and clinical review.
@en
P2093
P2860
P2888
P356
10.1038/BJC.1997.328
P407
P577
1997-01-01T00:00:00Z
P5875
P6179
1040418922